XSES
C2PU
Market cap1.99bUSD
Jun 18, Last price
3.93SGD
1D
-0.76%
1Q
-2.72%
Jan 2017
66.53%
IPO
216.94%
Name
Parkway Life Real Estate Investment Trust
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||